Charles B. Davis

2.7k total citations
67 papers, 1.8k citations indexed

About

Charles B. Davis is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Charles B. Davis has authored 67 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 12 papers in Radiology, Nuclear Medicine and Imaging and 9 papers in Molecular Biology. Recurrent topics in Charles B. Davis's work include Monoclonal and Polyclonal Antibodies Research (12 papers), Water Quality and Resources Studies (6 papers) and Drug Transport and Resistance Mechanisms (5 papers). Charles B. Davis is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (12 papers), Water Quality and Resources Studies (6 papers) and Drug Transport and Resistance Mechanisms (5 papers). Charles B. Davis collaborates with scholars based in United States, United Kingdom and Australia. Charles B. Davis's co-authors include Qiao Hu, Roger J. McNichols, Robert Aggeler, Jason S. Lewis, Brian M. Zeglis, Brian Agnew, Elisabeth A. Minthorn, Deborah Kwok, Lisa J. Benincosa and Hee Chol Kang and has published in prestigious journals such as Nucleic Acids Research, Circulation and Journal of Clinical Oncology.

In The Last Decade

Charles B. Davis

63 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charles B. Davis United States 24 437 350 308 256 207 67 1.8k
Abraham J. Wilhelm Netherlands 24 311 0.7× 207 0.6× 354 1.1× 106 0.4× 103 0.5× 61 1.7k
David Z. D’Argenio United States 26 594 1.4× 243 0.7× 326 1.1× 140 0.5× 249 1.2× 96 2.3k
Pascal Girard France 27 366 0.8× 201 0.6× 602 2.0× 170 0.7× 103 0.5× 102 2.3k
Justyna Siwy Germany 27 859 2.0× 113 0.3× 174 0.6× 290 1.1× 171 0.8× 94 2.4k
Peter Furness United Kingdom 32 643 1.5× 156 0.4× 228 0.7× 864 3.4× 230 1.1× 146 3.4k
Daniel Wahl United States 23 780 1.8× 204 0.6× 503 1.6× 226 0.9× 249 1.2× 79 2.2k
William L. Bigbee United States 31 1.8k 4.1× 469 1.3× 479 1.6× 179 0.7× 163 0.8× 80 3.2k
Xiaoyu Jia United States 28 491 1.1× 415 1.2× 1.4k 4.5× 425 1.7× 237 1.1× 65 3.2k
Takamitsu Inoue Japan 30 888 2.0× 116 0.3× 747 2.4× 633 2.5× 221 1.1× 230 2.9k
Jian Lü China 22 396 0.9× 90 0.3× 185 0.6× 283 1.1× 230 1.1× 71 1.7k

Countries citing papers authored by Charles B. Davis

Since Specialization
Citations

This map shows the geographic impact of Charles B. Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles B. Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles B. Davis more than expected).

Fields of papers citing papers by Charles B. Davis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles B. Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles B. Davis. The network helps show where Charles B. Davis may publish in the future.

Co-authorship network of co-authors of Charles B. Davis

This figure shows the co-authorship network connecting the top 25 collaborators of Charles B. Davis. A scholar is included among the top collaborators of Charles B. Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles B. Davis. Charles B. Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Briggs, Karen K., Erik Wilker, Charles B. Davis, et al.. (2022). 24P Evidence for synergy between TNG908, an MTAPnull-selective PRMT5 inhibitor, and sotorasib in an MTAPnull/KRASG12C xenograft model. Annals of Oncology. 33. S12–S12. 3 indexed citations
2.
Briggs, Kimberly J., Kevin M. Cottrell, Erik Wilker, et al.. (2022). Abstract 3941: TNG908 is an MTAPnull-selective PRMT5 inhibitor that drives tumor regressions in MTAP-deleted xenograft models across multiple histologies. Cancer Research. 82(12_Supplement). 3941–3941. 5 indexed citations
3.
Hu, Shaojing, Guojian Xie, Charles B. Davis, et al.. (2012). Synthesis and biological evaluation of crown ether fused quinazoline analogues as potent EGFR inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(19). 6301–6305. 46 indexed citations
4.
Davis, Charles B.. (2011). CONJOINED TWINS AS PERSONS THAT CAN BE VICTIMS OF HOMICIDE. Medical Law Review. 19(3). 430–466. 5 indexed citations
5.
Lan, Tian, Anuradha Rao, Jamie Haywood, et al.. (2009). Interaction of Macrolide Antibiotics with Intestinally Expressed Human and Rat Organic Anion-Transporting Polypeptides. Drug Metabolism and Disposition. 37(12). 2375–2382. 40 indexed citations
6.
Han, Chao, et al.. (2009). Prediction of animal clearance using naïve Bayesian classification and extended connectivity fingerprints. Xenobiotica. 39(7). 487–494. 8 indexed citations
7.
Minthorn, Elisabeth A., Thomas Mencken, Andrew G. King, et al.. (2008). Pharmacokinetics and Brain Penetration of Casopitant, a Potent and Selective Neurokinin-1 Receptor Antagonist, in the Ferret. Drug Metabolism and Disposition. 36(9). 1846–1852. 23 indexed citations
8.
Garver, Eric, et al.. (2008). Involvement of Intestinal Uptake Transporters in the Absorption of Azithromycin and Clarithromycin in the Rat. Drug Metabolism and Disposition. 36(12). 2492–2498. 34 indexed citations
9.
Davis, Charles B., Ramesh Bambal, Ganesh S. Moorthy, et al.. (2008). Comparative preclinical drug metabolism and pharmacokinetic evaluation of novel 4-aminoquinoline anti-malarials. Journal of Pharmaceutical Sciences. 98(1). 362–377. 12 indexed citations
10.
Stokes, María, Charles B. Davis, Gilbert Koch, et al.. (2006). Survival Analysis: A Self‐Learning Text by D.G. Kleinbaum and M. Klein. Biometrics. 62(1). 312–312.
11.
Davis, Charles B., et al.. (2000). Comparative Pharmacodynamics of Keliximab and Clenoliximab in Transgenic Mice Bearing Human CD4. Journal of Pharmacology and Experimental Therapeutics. 293(1). 33–41. 23 indexed citations
12.
Zia‐Amirhosseini, Parnian, Robert Z. Harris, Hugh Cowley, et al.. (2000). Pharmacokinetics of a Hematoregulatory Peptide (SK&F 107647) in Healthy Male Volunteers and in Patients with Colorectal or Pancreatic Adenocarcinoma Not Amenable to Standard Therapy. Pharmaceutical Research. 17(4). 385–390. 2 indexed citations
13.
Davis, Charles B. & Roger J. McNichols. (1999). Simultaneous Nonparametric Prediction Limits. Technometrics. 41(2). 89–101. 2 indexed citations
14.
Mould, Diane R., Charles B. Davis, Elisabeth A. Minthorn, et al.. (1999). A population pharmacokinetic-pharmacodynamic analysis of single doses of clenoliximab in patients with rheumatoid arthritis. Clinical Pharmacology & Therapeutics. 66(3). 246–257. 52 indexed citations
15.
Davis, Charles B., Rudolf Avenhaus, & Morton John Canty. (1999). Compliance Quantified: An Introduction to Data Verification. Technometrics. 41(2). 174–174. 8 indexed citations
16.
Everitt, Daniel E., Charles B. Davis, Katherine A. Thompson, et al.. (1996). The Pharmacokinetics, Antigenicity, and Fusion-Inhibition Activity of RSHZ19, a Humanized Monoclonal Antibody to Respiratory Syncytial Virus, in Healthy Volunteers. The Journal of Infectious Diseases. 174(3). 463–469. 41 indexed citations
17.
Davis, Charles B., Deborah Kwok, T K Hart, et al.. (1995). Preclinical pharmacokinetic evaluation of the respiratory syncytial virus-specific reshaped human monoclonal antibody RSHZ19.. Drug Metabolism and Disposition. 23(10). 1028–1036. 26 indexed citations
18.
Davis, Charles B. & Robert M. Beecher. (1988). The statistical use of fourier descriptors. Mathematical and Computer Modelling. 11. 419–424. 1 indexed citations
19.
Davis, Charles B. & Roger J. McNichols. (1987). One-Sided Intervals for at Least p of m Observations From a Normal Population on Each of r Future Occasions. Technometrics. 29(3). 359–370. 3 indexed citations
20.
Davis, Charles B., et al.. (1960). Effect of Mixed Fat Formula Feeding on Serum Cholesterol Level in Man. American Journal of Clinical Nutrition. 8(6). 808–811. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Abraham J. Wilhelm Breakdown of academic impact, for papers by David Z. D’Argenio Breakdown of academic impact, for papers by Pascal Girard Breakdown of academic impact, for papers by Justyna Siwy Breakdown of academic impact, for papers by Peter Furness Breakdown of academic impact, for papers by Daniel Wahl Breakdown of academic impact, for papers by William L. Bigbee Breakdown of academic impact, for papers by Xiaoyu Jia Breakdown of academic impact, for papers by Takamitsu Inoue Breakdown of academic impact, for papers by Jian Lü
Rankless by CCL
2026